Skip to main content
Egyptian Liver Journal

Table 3 Descriptive analysis of different DAAs treatment regimens received by the studied cases

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

 

Studied patients

(no. = 80)

No

%

SOF/DAC

56

70.0%

SOF/DAC/RBV

24

30.0%

  1. Seventy-seven (96.25%) patients achieved SVR, while 3 (3.75%) patients relapsed
Back to article page